The association between baseline IgE level and urticaria control at six months of omalizumab treatment in chronic urticaria

There is limited data on the use of baseline IgE level as a predictor of omalizumab response in chronic urticaria (CU). The aim of the present study was to determine if baseline serum total IgE level is associated with response at six months of standard-dose omalizumab.